Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Results of the 2001 AcroMetrix HIV-1 resistance proficiency program.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology - 1 Dec 2002

Neuwald Paul D, Funelas Maria B, DelCarmen John P, Raybold Arthur W, Jorgensen Paul A

Abstract excerpt

BACKGROUND: Human immunodeficiency virus type 1 (HIV-1) drug resistance mutation testing has become a useful tool in assessing antiretroviral treatment and managing patient care. As these complex molecular genotyping procedures move into routine use in clinical laboratories, the need arises for quality control procedures that will ensure that drug resistance associated mutations are accurately identified....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Reverse Transcriptase

Share to Laboratories

Share to Program Evaluation

Share to Quality Control

Source

Identifiers

PMID: 12467778
DOI: 10.1016/s1386-6532(02)00191-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Results of the 2001 AcroMetrix HIV-1 resistance proficiency program.PMID 12467778Read ↗

Genotyping External Quality Assurance in the World Health Organization HIV Drug Resistance Laboratory Network During 2007–2010Semantic proximity Read ↗

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.Semantic proximity Read ↗

Model for assessment of proficiency of human immunodeficiency virus type 1 sequencing-based genotypic antiretroviral assays.Semantic proximity Read ↗

[Evaluation of the consistency of three methods for testing HIV-1 genotype drug resistance].Semantic proximity Read ↗

HIV-1 drug resistance genotyping quality assessment: Results of the ENVA7 Genotyping Proficiency ProgrammeSemantic proximity Read ↗

Accuracy, precision, and consistency of expert HIV type 1 genotype interpretation: an international comparison (The GUESS Study).Semantic proximity Read ↗

Worldwide evaluation of DNA sequencing approaches for identification of drug resistance mutations in the human immunodeficiency virus type 1 reverse transcriptase.Semantic proximity Read ↗

Resistance and replication capacity assays: clinical utility and interpretation.Semantic proximity Read ↗

Quality control trial for human immunodeficiency virus type 1 drug resistance testing using clinical samples reveals problems with detecting minority species and interpretation of test results.Semantic proximity Read ↗

Repeated HIV-1 resistance genotyping external quality assessments improve virology laboratory performance.Semantic proximity Read ↗

[The outer quality control of identification of mutations of HIV drug resistance to anti-retrovirus preparations: the results of "HIV resistance-2009" program].Semantic proximity Read ↗

Evaluation of the editing process in human immunodeficiency virus type 1 genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.